Minerva Neurosciences, Inc. (NERV)
NASDAQ·Healthcare·Biotechnology
$6.45
+0.31%
Mkt Cap $55.94M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
-22.5%
Consensus $5.00 vs current $6.45
NASDAQ·Healthcare·Biotechnology
$6.45
+0.31%
Mkt Cap $55.94M
No recent rating data.
Price Target (3 analysts)
$5.00
Range $5.00 – $5.00
-22.5%
Consensus $5.00 vs current $6.45